Role of Epigenetics in Chronic Myeloid Leukemia

被引：0
作者：
Katerina Machova Polakova
Jitka Koblihova
Tomas Stopka
机构：
[1] Institute of Hematology and Blood Transfusion,Institute of Pathophysiology, First Faculty of Medicine
[2] Charles University in Prague,undefined
来源：
Current Hematologic Malignancy Reports | 2013年 / 8卷
关键词：
CML; Epigenetics; microRNA; Tyrosine kinase inhibitors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The efficacy of therapeutic modalities in chronic myeloid leukemia (CML) depends on both genetic and epigenetic mechanisms. This review focuses on epigenetic mechanisms involved in the pathogenesis of CML and in resistance of tumor cells to tyrosine kinase inhibitors leading to the leukemic clone escape and propagation. Regulatory events at the levels of gene regulation by transcription factors and microRNAs are discussed in the context of CML pathogenesis and therapeutic modalities.
引用
收藏
页码：28 / 36
页数：8
相关论文
共 176 条
  • [1] Nowell PC(1960)A minute chromosome in human chronic granulocytic leukemia Science 142 1497-93
  • [2] Hungerford DA(1973)Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining Nature 243 290-66
  • [3] Rowley JD(1996)Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells Nat Med 2 561-80
  • [4] Druker BJ(2001)Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification Science 293 876-15
  • [5] Tamura S(2011)BCR-ABL kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European LeukemiaNet Blood 118 1208-80
  • [6] Buchdunger E(2001)Translating the histone code Science 293 1074-83
  • [7] Gorre ME(2001)RNA: guiding gene silencing Science 293 1080-25
  • [8] Mohammed M(2011)Chromatin mechanisms regulating gene expression in health and disease Adv Exp Med Biol 711 12-60
  • [9] Ellwood K(1999)ABL1 methylation is a distinct molecular event associated with clonal evolution of chronic myeloid leukemia Blood 94 2452-80
  • [10] Soverini S(1999)Methylation of the ABL1 promoter in chronic myelogenous leukemia: lack of prognostic significance Blood 93 2075-23
12345678910